These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 7506644)

  • 1. Prospective assessment of incidence of fulminant hepatitis in post-transfusion hepatitis: a study of 504 cases.
    Takano S; Omata M; Ohto M; Satomura Y
    Dig Dis Sci; 1994 Jan; 39(1):28-32. PubMed ID: 7506644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low incidence of non-A, non-B post-transfusion hepatitis in London confirmed by hepatitis C virus serology.
    Contreras M; Barbara JA; Anderson CC; Ranasinghe E; Moore C; Brennan MT; Howell DR; Aloysius S; Yardumian A
    Lancet; 1991 Mar; 337(8744):753-7. PubMed ID: 1672391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies to hepatitis C virus in prospectively followed patients with posttransfusion hepatitis.
    Lee SD; Hwang SJ; Lu RH; Lai KH; Tsai YT; Lo KJ
    J Infect Dis; 1991 Jun; 163(6):1354-7. PubMed ID: 1645386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Posttransfusion hepatitis in Japan.
    Takano S; Omata M; Ohto M; Satomura Y
    Vox Sang; 1992; 62(3):156-64. PubMed ID: 1609517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective assessment of donor blood screening for antibody to hepatitis C virus and high-titer antibody to HBcAg as a means of preventing posttransfusion hepatitis.
    Takano S; Omata M; Ohto M; Satomura Y
    Hepatology; 1993 Aug; 18(2):235-9. PubMed ID: 8393422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis C virus in a prospective study of posttransfusion non-A, non-B hepatitis in Taiwan.
    Wang JT; Wang TH; Lin JT; Sheu JC; Sung JL; Chen DS
    J Med Virol; 1990 Oct; 32(2):83-6. PubMed ID: 2177776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HCV infection and its clinical features in recipients of blood screened for HCV (C100-3) antibody.
    Ito S; Honda H; Hibino S; Nii C; Kamamura M; Nishikado T; Fujikawa H; Saijo T; Okamura S; Shimizu I
    J Gastroenterol Hepatol; 1994; 9(1):19-25. PubMed ID: 8155861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-HCV in post-transfusion hepatitis: deductions from a prospective study.
    Feinman SV; Berris B; Herst R
    J Hepatol; 1991 May; 12(3):377-81. PubMed ID: 1658122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seroconversion to hepatitis C virus antibodies in patients with acute posttransfusion non-A, non-B hepatitis in Sweden.
    Mattsson L; Grillner L; von Sydow M; Bergdahl S; Weiland O
    Infection; 1991; 19(5):309-12. PubMed ID: 1666063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective study of posttransfusion hepatitis in Taiwan.
    Wang TH; Wang JT; Lin JT; Sheu JC; Sung JL; Chen DS
    J Hepatol; 1991 Jul; 13(1):38-43. PubMed ID: 1655869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of antibodies to hepatitis C virus in a study of transfusion-associated hepatitis.
    Esteban JI; González A; Hernández JM; Viladomiu L; Sánchez C; López-Talavera JC; Lucea D; Martin-Vega C; Vidal X; Esteban R
    N Engl J Med; 1990 Oct; 323(16):1107-12. PubMed ID: 2170839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impacts of blood screening on the incidence of posttransfusion hepatitis C in Japan.
    Yoshizawa H; Watanabe J
    Curr Stud Hematol Blood Transfus; 1994; (61):182-94. PubMed ID: 7525155
    [No Abstract]   [Full Text] [Related]  

  • 13. A multicenter, prospective study of posttransfusion hepatitis in Milan.
    Colombo M; Oldani S; Donato MF; Borzio M; Santese R; Roffi L; Viganó P; Cargnel A
    Hepatology; 1987; 7(4):709-12. PubMed ID: 3111967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [European Acute Transfusion Hepatitis Interferon Study (EATHIS)].
    Jullien AM; Dejean AM; Janot C; Trepo C
    Rev Fr Transfus Hemobiol; 1992 Jul; 35(3):199-204. PubMed ID: 1329792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seroconversion to hepatitis C virus in dialysis patients: a retrospective and prospective study.
    Medin C; Allander T; Roll M; Jacobson SH; Grillner L
    Nephron; 1993; 65(1):40-5. PubMed ID: 7692314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody to hepatitis C virus in post-transfusion hepatitis.
    Tremolada F; Casarin C; Tagger A; Ribero ML; Realdi G; Alberti A; Ruol A
    Ann Intern Med; 1991 Feb; 114(4):277-81. PubMed ID: 1846277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of hepatitis and seroconversion to hepatitis C virus after open-heart surgery in transfused and non-transfused patients in Sweden.
    Mattsson L; Aberg B; von Sydow M; Weiland O
    Scand J Infect Dis; 1991; 23(1):25-9. PubMed ID: 1851323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Three cases of posttransfusion hepatitis C treated with interferon-alpha. Confirmation of a carrier state by detection of hepatitis C virus RNA after interferon therapy.
    Hagiwara H; Hayashi N; Kasahara A; Mita E; Takehara T; Fusamoto H; Kamada T
    Dig Dis Sci; 1992 Apr; 37(4):631-4. PubMed ID: 1312923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of hepatitis C virus infection in burn patients: detection of anti-C100, anti-C33c and anti-Core antibodies.
    Coursaget P; Lesage G; Simpson B; Mayelo V; Le Cann P
    Biomed Pharmacother; 1991; 45(10):445-9. PubMed ID: 1668142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of posttransfusion hepatitis B and C by screening for antibody to hepatitis C virus and antibody to HBcAg.
    Chung HT; Lee JS; Lok AS
    Hepatology; 1993 Nov; 18(5):1045-9. PubMed ID: 7693569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.